; 95% CI, 0.18-1.11;
P < .08); however, these differences were not signiﬁcant.
If CREST patients older than 80 years are removed to
allow CREST to be compared with other trials, results
from the symptomatic cohort demonstrated that
30-day stroke and death risk was signiﬁcantly lower
among the patients undergoing CEA (2.6%þ0.7%